ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
1.640
-0.020 (-1.20%)
At close: Aug 1, 2025, 4:00 PM
1.610
-0.030 (-1.83%)
After-hours: Aug 1, 2025, 7:58 PM EDT

ImmunoPrecise Antibodies Stock Forecast

Stock Price Forecast

The 2 analysts that cover ImmunoPrecise Antibodies stock have a consensus rating of "Strong Buy" and an average price target of $4.00, which forecasts a 143.90% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $5.00.

Price Target: $4.00 (+143.90%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$3.00$4.00$5.00$5.00
Change+82.93%+143.90%+204.88%+204.88%
* Price targets were last updated on Apr 11, 2025.

Analyst Ratings

The average analyst rating for ImmunoPrecise Antibodies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy111111
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5
Strong BuyReiterates$5+204.88%Apr 11, 2025
Benchmark
Benchmark
Buy
Reiterates
$3
BuyReiterates$3+82.93%Apr 1, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$7$5
Strong BuyMaintains$7$5+204.88%Mar 31, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong BuyReiterates$7+326.83%Mar 14, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$9$7
Strong BuyMaintains$9$7+326.83%Dec 11, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
25.66M
from 24.52M
Increased by 4.67%
Revenue Next Year
29.30M
from 25.66M
Increased by 14.15%
EPS This Year
-0.64
from -1.06
EPS Next Year
-0.11
from -0.64
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingApr 30, 2020Apr 30, 2021Apr 30, 2022Apr 30, 2023Apr 30, 2024Apr 30, 2025Apr 30, 2026Apr 30, 2027
Revenue
14.06M17.91M19.36M20.67M24.52M25.66M29.30M38.70M
Revenue Growth
28.66%27.42%8.11%6.72%18.65%4.67%14.15%32.09%
EPS
-0.36-0.45-0.85-1.07-1.06-0.64-0.110.02
EPS Growth
--------
Forward PE
-------111.98
No. Analysts
-----322
Financial currency is CAD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027202820292030
High27.4M30.5M40.2M
Avg25.7M29.3M38.7M
Low24.2M28.4M37.5M

Revenue Growth

Revenue Growth202520262027202820292030
High
11.9%
18.7%
37.3%
Avg
4.7%
14.1%
32.1%
Low
-1.3%
10.8%
28.2%

EPS Forecast

EPS202520262027
High-0.26-0.120.02
Avg-0.64-0.110.02
Low-0.99-0.110.02

EPS Growth

EPS Growth202520262027
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.